What Happened?
San Diego, CA-based Primmune-Therapeutics Appointed Charlie McDermott as Chairman, President and Chief Executive Officer
Date of management change: March 15, 2019
San Diego, CA-based Primmune-Therapeutics Appointed Charlie McDermott as Chairman, President and Chief Executive Officer
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
Charlie McDermott is Chairman, President and Chief Executive Officer at Primmune Therapeutics. Previously, Charlie held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: McGilvray Adam, Ganesan Anitha, Houck Schyler, Mortellaro Kayla, Boland Linda, Park Julian, Browne Janelle, Curtiss Elaine, Sullivan Lisa, Badiozamani Ghazal, Spence Jeff
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.